ITFG/IPAC Collaboration CMC Leachables and Extractables Technical Team ITFG/IPAC TECHNICAL TEAM: CMC LEACHABLES AND EXTRACTABLES Presented by: Kaushik.

Slides:



Advertisements
Similar presentations
Roadmap for Sourcing Decision Review Board (DRB)
Advertisements

Practical Quantitation Limit Guidance Presentation to WQ Forum November 20, 2006.
April 6, 2011 DRAFT Educator Evaluation Project. Teacher Education and Licensure DRAFT The ultimate goal of all educator evaluation should be… TO IMPROVE.
Best Practices for OINDP Pharmaceutical Development Programs Leachables and Extractables PQRI Leachables & Extractables Working Group PQRI Training Course.
DR MACIEJ JUNKIERT PRACOWNIA BADAŃ NAD TRADYCJĄ EUROPEJSKĄ Guide for Applicants.
12-1 Chapter Twelve INSTRUMENTS OF PARTICIPANT COMMUNICATION.
Florida Pilot Initiative for the Performance Approach to Measurement Systems Stephen Arms Florida Department of Health.
NIH Mentored Career Development Awards (K Series) Part 2 Thomas Mitchell, MPH Department of Epidemiology & Biostatistics University of California San Francisco.
VALIDATION What is the new guidance?. What is a Compliance Policy Guide? Explain FDA policy on regulatory issues CGMP regulations and application commitments.
[Title of meeting] [Name of sponsor] [Date] For guidance on working with PowerPoint and reformatting slides, click on Help, then Microsoft PowerPoint Help,
Integrating CMC Review & Inspection Industry Recommendations Joe Anisko April 24, 2003.
COMPARABILITY PROTOCOLS ACPS March 12-13, 2003 Stephen K. Moore, Ph.D. Chemistry Team Leader CDER/Office of New Drug Chemistry Co-Chair, Comparability.
Assessing Quality-by-Design A CMC Review Perspective
FAO/WHO CODEX TRAINING PACKAGE
Training Workshop on Pharmaceutical Development with a Focus on Paediatric Medicines / October |1 | Regulatory Requirement on Dossier of Medicinal.
Research & Innovation Horizon societal challenge 1 Open Info Day Funding Opportunities for SMEs Horizon 2020 "Health, demographic change and wellbeing"
Top Tactics for Maximizing GMP Compliance in Blue Mountain RAM Jake Jacanin, Regional Sales Manager September 18, 2013.
September 2006PQRI Training Course1 Best Practices for OINDP Pharmaceutical Development Programs Leachables and Extractables VIII. Quality Control and.
Best Practices for OINDP Pharmaceutical Development Programs Leachables and Extractables PQRI Leachables & Extractables Working Group VI. Characterization.
ISA–The Instrumentation, Systems, and Automation Society SP99 Work Group 2 TR#2 “Second Edition” Long Beach Meeting April 28, 2004.
Selection Sourcing Structure Standardization Safety Substantiation
ITFG/IPAC Collaboration OVERVIEW OF ITFG/IPAC COLLABORATION Presented by: Harris Cummings, PhD 26 April 2000 Rockville, MD.
Achieving and Demonstrating “Quality-by-Design” with Respect to Drug Release/dissolution Performance for Conventional or Immediate Release Solid Oral Dosage.
1 Process to Address Specifications for Delivered Dose Uniformity of Inhaled and Nasal Drug Products Presented by Robert O’Neill, Ph.D. Chair ACPS Working.
December 2010 Project Director’s Report OIDAP Quarterly Meeting Baltimore, MD Sylvia Karman OIDAP Member & Director, Office of Vocational Resources Development.
Nonclinical Studies Subcommittee Advisory Committee for Pharmaceutical Science CMC Issues for Screening INDs Eric B. Sheinin, Ph.D. Acting Deputy Director.
ITFG/IPAC Collaboration CMC Specifications Technical Team ITFG/IPAC TECHNICAL TEAM: CMC SPECIFICATIONS Presented by: Bo Olsson, PhD 26 April 2000 Rockville,
Industry Perspective on Challenges for Product Developers - Drugs Christine Allison, M.S., RAC Associate Regulatory Consultant, Global Regulatory Affairs.
1 Supplements and Other Changes to an Approved Application By: Richard J. Stec Jr., Ph.D. February 7, 2007.
Evaluation methods and tools (Focus on delivery mechanism) Jela Tvrdonova, 2014.
Oregon Toxics Reduction Strategy: Tools and Initiatives June 25, NW NAHMMA Conference Kevin Masterson, Oregon DEQ Agency Toxics Coordinator
FAO/WHO Codex Training Package Module 3.2 FAO/WHO CODEX TRAINING PACKAGE SECTION THREE – BASICS OF NATIONAL CODEX ACTIVITIES 3.2 How to develop national.
Mark Barnes David Forster July 21, 2010 Subcommittee on Harmonization (SOH) Update.
Exploratory IND Studies
Nursing Research Capacity Building. Background CON –opened as 9 th College at SQU in 2008 The CON’s next challenge is promoting nursing care based on.
Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.
SAON Data Management Workshop Report June 7-8, 2010, Norway Recommendations (Extracted by Jan René Larsen, 25 September 2012),
FDA Recommendations: Sampling Plans for Blood Establishments Lore Fields MT(ASCP)SBB Consumer Safety Officer OBRR/CBER/FDA October 19, 2012.
United States Department of Agriculture Food Safety and Inspection Service 1 National Advisory Committee on Meat and Poultry Inspection August 8-9, 2007.
IRIS - International Railway Industry Standard The Quality Standard for the Railway Industry ACRI Prague, 2nd April 2008 Angela de Heymer Manager Quality.
Bioequivalence Studies and Other Recommendations for Orally Inhaled and Nasal Drug Products: Work of the ITFG/IPAC-RS Collaboration Presented by Cynthia.
Presented by CIDA on behalf of the Task Team on Multilateral Effectiveness.
Ivowen Ltd1 Ivowen Limited Preparation and Submission of a Traditional Herbal Medicinal Product Application.
COMPARABILITY PROTOCOLUPDATE ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE Manufacturing Subcommittee July 20-21, 2004 Stephen Moore, Ph.D. Chemistry Team.
BBSST: Building Based Student Support Team Blount County Schools James E. Carr Superintendent.
Product Assurance CQSDI Break-Out Session Presented By: Mike Bath Space & Missile Systems Division March 27, 2007.
Progress in FDA’s Drug Product Quality Initiative Janet Woodcock, M.D. November 13, 2003.
General Aspects of Quality assessment of multisource interchangeable medicines Rutendo Kuwana Technical Officer, WHO, Geneva Training workshop: Assessment.
ITFG/IPAC Collaboration Introduction OVERVIEW OF ITFG/IPAC COLLABORATION Presented by: Harris Cummings, PhD 26 April 2000 Rockville, MD.
ITFG/IPAC Collaboration BA/BE Technical Team ITFG/IPAC TECHNICAL TEAM: BA/BE IN VITRO AND IN VIVO TESTS Presented by: Stephen Farr, PhD 26 April 2000 Rockville,
ITFG/IPAC Collaboration CMC Supplier Quality Control Technical Team ITFG/IPAC TECHNICAL TEAM: SUPPLIER QUALITY CONTROL (QUALIFICATION) Presented by: Gordon.
Lawrence X. Yu, Ph.D. Director for Science Office of Generic Drugs, OPS, CDER, FDA ACPS Meeting, ACPS Meeting, Oct. 22, 2003 Office of Generic Drugs Research.
Evaluation of quality and interchangeability of medicinal products - WHO Training workshop / 5-9 November |1 | Prequalification programme: Priority.
Use of Risk-based Approach for Regulating CMC Changes to Approved Applications FDA Public Meeting February 7, 2007.
Data, Infrastructure and Markets Workgroup. Workgroup Meetings Held two meetings – March 31 and April 19 Primary Discussion Topics Data and analysis needs.
Training on Safe Hospitals in Disasters Module 3: Action Planning for “Safe Hospitals”
Orally Inhaled and Nasal Drug Products (OINDP) Subcommittee Report to the Advisory Committee for Pharmaceutical Sciences Rockville, Maryland November 15,
RCC Update ORS Quarterly Meeting April 28, 2016 Julie Cole, Director Research Costing Compliance.
Abstract A step-wise or ‘tiered’ approach has been used as a rational procedure to conduct environmental risk assessments in many disciplines. The Technical.
Manufacturing Process of Drug Product: Container closure system Compatibility Ratiya KUKHETPITAKWONG 27 April 2016.
Office of Pharmaceutical Science OPS Center for Drug Evaluation and Research CDER FDA Food and Drug Administration HHS Health and Human Services 1 Advisory.
DIA ERS SIAC IND CMC eCTD Submissions Part II – IND to NDA
Pre-Investigational New Drug (pre-IND) Meeting with FDA
Updating the Regulation for the JINR Programme Advisory Committees
The Policies and Processes of the WFME Recognition Program
Rating in 2002 for funding from 2003
Roles and Responsibilities
Quality guidelines on impurities
Evidence-Based Public Health
Guideline for Elemental Impurities ICH Q3D(R)
Presentation transcript:

ITFG/IPAC Collaboration CMC Leachables and Extractables Technical Team ITFG/IPAC TECHNICAL TEAM: CMC LEACHABLES AND EXTRACTABLES Presented by: Kaushik J. Dave, R.Ph, PhD 26 April 2000 Rockville, MD

ITFG/IPAC Collaboration CMC Leachables and Extractables Technical Team LEACHABLES AND EXTRACTABLES TECHNICAL TEAM The Team recognizes that control of extractables and leachables is important for ensuring the safety and quality of inhalation drug products CMC Leachables and Extractables Technical Team

ITFG/IPAC Collaboration CMC Leachables and Extractables Technical Team DEFINITIONS Extractables: Compounds that can be extracted from the elastomeric or plastic components, or coatings of the container closure system when in contact with appropriate solvent(s). Leachables: Compounds that leach into the formulation from the elastomeric or plastic components, or coatings of the container and closure system as a result of direct contact with the formulation. CMC Leachables and Extractables Technical Team

ITFG/IPAC Collaboration CMC Leachables and Extractables Technical Team TEAM’S FOCUS The Team has identified four key areas of the draft CMC guidances for clarification and/or further investigation: Analytical Characterization of Extractables (Control Extraction Studies) Analytical Characterization of Leachables Safety Qualification of Leachables Routine Extractables Testing CMC Leachables and Extractables Technical Team

ITFG/IPAC Collaboration CMC Leachables and Extractables Technical Team TEAM’S TOPICS FOR STUDY 1. Analytical Characterization of Extractables (Control Extraction Studies) The Team requests clarification and will propose alternate language with respect to the specific requirements for control extraction studies (e.g., determination of which critical components are required for extractables analysis ) CMC Leachables and Extractables Technical Team

ITFG/IPAC Collaboration CMC Leachables and Extractables Technical Team 2. Analytical Characterization of Leachables How is a correlation with extractables established? The Team will prepare a review of available leachables data and examine it for correlation with the corresponding extractables data. A working definition of correlation will be proposed based on an examination of the data. TEAM’S TOPICS FOR STUDY CMC Leachables and Extractables Technical Team

ITFG/IPAC Collaboration CMC Leachables and Extractables Technical Team 3. Safety Qualification of Leachables What are current industry practices for establishing safety of leachables? The Team’s Working Group on Toxicology will survey current industry practices and will propose a strategy for safety qualification of leachables based on best practices (e.g., What are the qualification criteria? Does ICH apply?) TEAM’S TOPICS FOR STUDY CMC Leachables and Extractables Technical Team

ITFG/IPAC Collaboration CMC Leachables and Extractables Technical Team 4. Routine Extractables Testing Is quantitative testing of extractables appropriate for control of composition of all components? The Leachables and Extractables Team, in collaboration with Supplier QC Team, will propose a control strategy combining appropriate scientific practices, cGMP controls and supplier qualification systems for ensuring the relevant performance and safety characteristics of critical components TEAM’S TOPICS FOR STUDY CMC Leachables and Extractables Technical Team

ITFG/IPAC Collaboration CMC Leachables and Extractables Technical Team TEAM’S APPROACH AND COMMITMENT The Team is committed to offer data-based technical reports and recommendations to the Agency and the OINDP Subcommittee within 3-4 months. The Team is available to evaluate any extractable and leachable issue which the Agency and the OINDP Subcommittee request. CMC Leachables and Extractables Technical Team